Between 30 million and 50 million men in the US have erectile dysfunction, including a staggering 70% of men over 70.

Hims and Hers, the D2C marketer of erectile disfunction (ED) pills and other health and wellness products, is now now combining those ED drugs with cholesterol-lowering statins as it enters the ...

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission Here’s our process. Hims is a telehealth company specializing in male ...

Hims & Hers Health Inc (NYSE: HIMS) isn't just chasing wellness trends — it's building a global health platform. At the ...

Erectile dysfunction (ED) is inconvenient enough on its own. The last thing you want is a pile-on of other inconveniences, like having to go to a doctor’s office for a diagnosis and prescription — and ...

Nothing can ruin a romantic date night like the anxiety that often accompanies erectile dysfunction (ED). While the condition is often addressed behind closed doors, it is extremely common. Studies ...

At some point in their lives, nearly 50% of men will experience hair loss due to stress, genetics, or hormone imbalance. Up to 40% of males over age 40 experience erectile dysfunction (ED). These are ...

After Covid-19, the world has changed drastically. The need to provide healthcare services through online mode is one such change, and this has proven to be a boon for men. As men tend to stay in ...

BlueChew is a web-based service providing erectile dysfunction (ED) medication for men. When you subscribe to BlueChew, they will offer chewable ED tablets that work in 20 to 30 minutes by increasing ...

Spruce Capital Management issued a short report on Hims & Hers Health, Inc., but the call actually only forecast downside risk to $5. The health and wellness company continues to grow at a fast clip ...